
Overview
Manufacturer's fiscal Q1 revenue met analyst expectations, non-GAAP EPS hit high end of guidance
Company won 22 manufacturing programs, representing $283 mln in annualized revenue
Company repurchased $22.4 mln of shares under 2026 Share Repurchase Program
Outlook
Plexus forecasts Q2 revenue of $1.110 bln to $1.150 bln
Company expects Q2 GAAP EPS of $1.53 to $1.68
Plexus anticipates Q2 non-GAAP EPS of $1.80 to $1.95
CASH FLOW OUTLOOK - Despite cash usage in Q1, co expects $100 mln free cash flow for fiscal 2026
Result Drivers
HEALTHCARE AND AEROSPACE GROWTH - Revenue increased 10% year-over-year due to strong growth in Healthcare/Life Sciences and Aerospace/Defense sectors
MANUFACTURING WINS - Co secured 22 manufacturing wins, including $220 mln from Aerospace/Defense, contributing $283 mln in annualized revenue
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue | Meet | $1.07 bln | $1.07 bln (7 Analysts) |
Q1 EPS |
| $1.51 |
|
Q1 Net Income |
| $41.18 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the electronic equipment & parts peer group is "buy."
Wall Street's median 12-month price target for Plexus Corp is $157.50, about 9.2% below its January 27 closing price of $173.51
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 19 three months ago
Press Release: ID:nGNXPHLWm
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.